期刊
SEMINARS IN IMMUNOLOGY
卷 31, 期 -, 页码 55-63出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.smim.2017.08.003
关键词
NK cells; Innate lymphoid cells (ILC); Cancer; Immune checkpoint inhibitors (ICI); Immunoreceptor tyrosyne-based inhibitory motif (ITIM)
类别
资金
- European Research Council advanced grant
- Agence Nationale de la Recherche
- Ligue Nationale contre le Cancer (Equipe labellisee La Ligue)
- INSERM
- CNRS
- Aix-Marseille University
- Marseille Immunopole
After many years of research, recent advances have shed new light on the role of the immune system in advanced-stage cancer. Various types of immune cells may be useful for therapeutic purposes, along with chemical molecules and engineered monoclonal antibodies. The immune effectors suitable for manipulation for adoptive transfer or drug targeting in vivo include natural killer (NK) cells. These cells are of particular interest because they are tightly regulated by an array of inhibitory and activating receptors, enabling them to kill tumor cells while sparing normal cells. New therapeutic antibodies blocking the interactions of inhibitory receptors (immune checkpoint inhibitors, ICI) with their ligands have been developed and can potentiate NK cell functions in vivo.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据